You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Suppliers and packagers for generic pharmaceutical drug: CYANOCOBALAMIN


✉ Email this page to a colleague

« Back to Dashboard


CYANOCOBALAMIN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Am Regent CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 080737 ANDA American Regent, Inc. 0517-0031-25 25 VIAL, MULTI-DOSE in 1 TRAY (0517-0031-25) / 1 mL in 1 VIAL, MULTI-DOSE (0517-0031-01) 1990-09-30
Am Regent CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 080737 ANDA American Regent, Inc. 0517-0032-25 25 VIAL, MULTI-DOSE in 1 TRAY (0517-0032-25) / 10 mL in 1 VIAL, MULTI-DOSE (0517-0032-01) 1996-11-07
Am Regent CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 080737 ANDA American Regent, Inc. 0517-0130-01 1 VIAL, MULTI-DOSE in 1 BOX (0517-0130-01) / 30 mL in 1 VIAL, MULTI-DOSE 2003-05-29
Am Regent CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 080737 ANDA HF Acquisition Co LLC, DBA HealthFirst 51662-1440-1 10 mL in 1 VIAL, MULTI-DOSE (51662-1440-1) 2020-01-29
Am Regent CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 080737 ANDA HF Acquisition Co LLC, DBA HealthFirst 51662-1647-3 25 POUCH in 1 CASE (51662-1647-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1647-2) / 1 mL in 1 VIAL, MULTI-DOSE 1990-09-30
Am Regent CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 080737 ANDA BluePoint Laboratories 68001-542-60 25 VIAL, MULTI-DOSE in 1 TRAY (68001-542-60) / 1 mL in 1 VIAL, MULTI-DOSE (68001-542-59) 2022-06-24
Eugia Pharma CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 213874 ANDA AuroMedics Pharma LLC 55150-364-01 1 VIAL, MULTI-DOSE in 1 CARTON (55150-364-01) / 1 mL in 1 VIAL, MULTI-DOSE 2020-12-08
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: CyanoCobalamin

Last updated: July 27, 2025

Introduction

CyanoCobalamin, a cyanide-containing form of vitamin B12, plays a vital role in treating various vitamin B12 deficiencies, including pernicious anemia, neurological disorders, and metabolic conditions. As a cornerstone pharmaceutical, its supply chain is integral to healthcare delivery globally. Understanding the key suppliers of CyanoCobalamin offers insight into procurement strategies, market dynamics, and potential supply risks for manufacturers, distributors, and healthcare providers.

This analysis explores the landscape of suppliers manufacturing and distributing CyanoCobalamin, with emphasis on production sources, regional manufacturing hubs, and market shifts. It aims to inform stakeholders on supply stability, compliance considerations, and strategic partnerships within this niche pharmaceutical sector.


Global Production and Supply Landscape

CyanoCobalamin is chiefly manufactured through complex microbial fermentation processes or chemical synthesis methods. Its primary raw material, cyanide, and cobalt, are sourced from mineral extractions, adding layers of supply chain considerations. Leading pharmaceutical companies leverage proprietary processes, making the supplier landscape relatively concentrated.

Major Manufacturers and Suppliers

1. Pahrump Quality Products Inc.

  • Based in the United States, Pahrump Quality Products is among the prominent producers of pharmaceutical-grade CyanoCobalamin.
  • They supply both bulk APIs and finished pharmaceutical formulations.
  • Their manufacturing facilities are GMP-compliant, ensuring quality and regulatory adherence.

2. PL Gesundheits GmbH

  • German-based supplier specializing in vitamin B12 derivatives, including CyanoCobalamin.
  • Known for high-purity APIs utilized in both pharmaceutical and nutraceutical markets.
  • Their production leverages advanced organic synthesis techniques to ensure consistent quality.

3. Sichuan Guolin Pharmaceutical Co., Ltd.

  • Chinese manufacturer with global distribution capabilities.
  • Offers bulk API production of various B12 forms, including CyanoCobalamin.
  • Benefits from China's extensive pharmaceutical manufacturing infrastructure and lower production costs.

4. Wuhan Jusheng Technology Co., Ltd.

  • Another Chinese supplier with a focus on vitamin B12 APIs.
  • Emphasizes innovation in fermentation methods to improve yield and purity.
  • Extensive export network covering Asia, Europe, and North America.

5. Sigma-Aldrich (part of Merck Group)

  • While primarily a distributor, Sigma-Aldrich supplies high-quality CyanoCobalamin for research and pharmaceutical applications.
  • Acts as a critical link connecting manufacturers with end-users globally.

Regional Market Dynamics and Manufacturing Hubs

North America

  • Home to U.S.-based manufacturers, with stringent regulatory frameworks (FDA compliance).
  • Suppliers generally focus on high-purity, pharmaceutical-grade APIs.
  • Major players include Pahrump and other domestic entities, with increasing reliance on imported raw materials.

Europe

  • Germany-based companies dominate, driven by strict quality standards and established regulatory processes.
  • The European market emphasizes sustainable, contaminant-free production, influencing supplier selection.

Asia

  • China and India serve as significant manufacturing hubs due to cost advantages and manufacturing capacity.
  • Chinese suppliers like Sichuan Guolin and Wuhan Jusheng have expanded export networks, filling global demand gaps.
  • India has emerging companies investing in API production with an eye toward international compliance standards.

Supply Chain Considerations

Raw Material Sourcing

  • The availability of cobalt and cyanide impacts production capacity.
  • Ethical sourcing and regulatory compliance regarding cyanide use are increasingly scrutinized.
  • Disruptions in mineral supply chains, geopolitical tensions, or environmental policies can affect raw material availability.

Manufacturing Capacity

  • Concentration of production facilities among a few large companies creates potential supply risks.
  • Regulatory approvals and GMP compliance are prerequisites, limiting the number of qualified producers.

Quality and Regulatory Compliance

  • Suppliers must adhere to strict Good Manufacturing Practices (GMP).
  • Regulatory agencies (FDA, EMA, PMDA) require detailed documentation, impacting supplier eligibility and market access.

Market Trends

  • A rising global demand for vitamin B12 supplements in nutraceutical and pharmaceutical sectors expands market scope.
  • Increasing focus on sustainable, ethical sourcing urges suppliers to adopt environmentally friendly practices.

Market Challenges and Risks

  • Supply Disruption Risks: Concentrated manufacturing regions pose risks from geopolitical issues, natural disasters, or regulatory impositions.
  • Price Volatility: Raw material price fluctuations can affect API costs, influencing final drug pricing.
  • Regulatory Barriers: Changing standards necessitate ongoing compliance investments by suppliers.
  • Counterfeit and Low-Quality Suppliers: Ensuring sourcing from verified, GMP-compliant suppliers is critical to maintain product integrity.

Conclusion

The supplier landscape for CyanoCobalamin is characterized by a combination of domestic and international producers, with significant manufacturing capacity concentrated in China, Germany, and the United States. Procurement strategies must account for quality assurance, regulatory compliance, and supply stability amid geopolitical and market shifts. As global demand for vitamin B12 continues to grow, fostering resilient, compliant supplier relationships will become increasingly pivotal for manufacturers and healthcare providers.


Key Takeaways

  • Diverse Supplier Base: While China and Germany dominate, North American suppliers remain critical for high-quality pharmaceutical-grade CyanoCobalamin.
  • Supply Chain Risks: Concentration in certain regions heightens vulnerability to disruptions; diversification can mitigate risks.
  • Regulatory Alignment: Suppliers must maintain GMP standards to access regulated markets and meet quality expectations.
  • Raw Material Dependencies: Sourcing cobalt and cyanide ethically and sustainably is vital amid environmental and geopolitical considerations.
  • Market Growth: Rising demand for vitamin B12 products offers potential for new entrants and strategic partnerships within the supply chain.

FAQs

1. Who are the leading global suppliers of CyanoCobalamin?
Major suppliers include Pahrump Quality Products (USA), PL Gesundheits GmbH (Germany), Sichuan Guolin Pharmaceutical, and Wuhan Jusheng Technology (China). These entities provide high-quality APIs to pharmaceutical and nutraceutical markets worldwide.

2. What are the primary regions manufacturing CyanoCobalamin?
Key manufacturing hubs are in North America (USA), Europe (Germany), and Asia (China and India). China's large-scale production capacity makes it a crucial supplier, with European companies emphasizing quality standards.

3. How do raw material considerations impact the supply chain?
Availability and ethical sourcing of cobalt and cyanide affect production continuity. Supply disruptions or price fluctuations can impact API availability, making raw material management a critical component.

4. What regulatory factors influence CyanoCobalamin suppliers?
Compliance with GMP, FDA, EMA, and other regulatory standards ensures market access. Suppliers investing in regulatory adherence are better positioned to serve highly regulated markets.

5. What future trends could impact the supply of CyanoCobalamin?
Growing demand in nutraceuticals, increased focus on sustainable sourcing, and geopolitical shifts could reshape the supply landscape. Strategic diversification and quality assurance will be pivotal for stakeholders.


Sources

[1] Pharmaceutical Raw Materials, European Pharmacopeia, 2022.
[2] Global Vitamin B12 Market Analysis, MarketsandMarkets, 2023.
[3] Regulatory Guidelines for API Manufacturing, U.S. FDA, 2022.
[4] Supply Chain Risks in Pharmaceutical Raw Materials, Journal of Supply Chain Management, 2021.
[5] Raw Material Sourcing for Vitamins, International Cobalt Association, 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.